SCHEMBL26128173

SCHEMBL26128173

O=C(O)c1c(-c2nnn[nH]2)oc2ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 8/20 0.40
▸ ALDH1A1 P00352 6/20 0.40
▸ HSD17B10 Q99714 4/20 0.40
▸ LMNA P02545 3/20 0.40
▸ GAA P10253 3/20 0.40
▸ GLA P06280 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ MEN1 O00255 4/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ MAPK1 P28482 3/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ ALOX15 P16050 2/20 0.39
▸ TP53 P04637 2/20 0.39
▸ CA12 O43570 1/20 0.39
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ ABCB1 P08183 1/20 0.39
▸ CALM1 P0DP23 1/20 0.39
▸ AR P10275 1/20 0.39
▸ PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31652584 0.88 RAB9A (0.42) KDM4EALDH1A1HSD17B10LMNAGLA
SCHEMBL10372971 0.77 KDM4E (0.41) KDM4EALDH1A1LMNAGAAMEN1
SCHEMBL10370972 0.76 TSHR (0.48) KDM4EALDH1A1HSD17B10LMNATSHR
SCHEMBL8711671 0.75 DDR2 (0.56) KDM4EALDH1A1HSD17B10LMNAGAA
SCHEMBL7646411 0.74 NQO1 (0.42) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL5579331 0.74 KDM4E (0.57) KDM4EALDH1A1HSD17B10LMNAGAA
SCHEMBL24046932 0.72 MEN1 (0.64) KDM4EALDH1A1HSD17B10LMNAGAA
SCHEMBL3865070 0.71 ALDH1A1 (0.42) KDM4EALDH1A1HSD17B10LMNAGLA
SCHEMBL16794906 0.70 KDM4E (0.69) KDM4EALDH1A1HSD17B10LMNAGAA
SCHEMBL1520307 0.70 KMT2A (0.50) KDM4EALDH1A1HSD17B10LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250214976-A1 GPR35 MODULATORS AND USES THEREOF CROSSIGNAL THERAPEUTICS, INC. 2025-07-03 — — US disclosed
WO-2023196538-A1 GPR35 MODULATORS AND USES THEREOF CROSSIGNAL THERAPEUTICS, INC. (US) 2023-10-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250214976-A1 GPR35 MODULATORS AND USES THEREOF GPR35, GPR34, GPR68 KDM4E 3969/4885ALDH1A1 2672/4885HSD17B10 2934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback